Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trial

• Автори: Heiko Philippin, MD (Автор), Einoti Matayan, MMed (Автор), Karin M Knoll, MD (Автор), Edith Macha, Pharm Tech (Автор), Sia Mbishi, BSc (Автор), Andrew Makupa, MMed (Автор), Cristóvão Matsinhe, MMed (Автор), Vasco da Gama, MMed (Автор), Mario Monjane, MMed (Автор), Awum Joyce Ncheda, MMed (Автор), Francisco Alcides Mulobuana, MMed (Автор), Elisante Muna, MMed (Автор), Nelly Fopoussi, MMed (Автор), Gus Gazzard, ProfFRCOphth (Автор), Ana Patricia Marques, PhD (Автор), Peter Shah, ProfFRCOphth (Автор), David Macleod, PhD (Автор), William U Makupa, MMed (Автор), Matthew J Burton, ProfPhD (Автор)
• Формат: Книга
• Опубліковано: Elsevier, 2021-11-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Summary: Background: Glaucoma is a major cause of sight loss worldwide, with the highest regional prevalence and incidence reported in Africa. The most common low-cost treatment used to control glaucoma is long-term timolol eye drops. However, low adherence is a major challenge. We aimed to investig...